Mobile Menu - OpenMobile Menu - Closed

Newsroom

Latest News

Jul 18, 2017 Press Release
Subcommittee on Environment Ranking Member Paul Tonko's remarks on the House Floor during consideration of the Ozone Standards Implementation Act.
Jul 18, 2017 Press Release
Ranking Member Pallone's statement following Senate Majority Leader Mitch McConnell's signal that the Senate would attempt to repeal the Affordable Care Act after the Senate’s latest version of Trumpcare failed to gain enough votes to pass.
Issues:
Jul 18, 2017 Press Release
Ranking Member Frank Pallone, Jr. delivered the following opening remarks today at an Energy Subcommittee hearing on “Powering America: Examining the State of Electric Industry through Market Participant Perspectives:”
Jul 18, 2017 Press Release
Ranking Member Frank Pallone, Jr. delivered the following opening remarks today at an Oversight and Investigations Subcommittee hearing titled, “Examining HRSA’s Oversight of the 340B Drug Pricing Program:”
Issues:
Jul 17, 2017 In The News
Ranking Member Frank Pallone, Jr. spoke today at the Center for American Progress on ways to make prescription drugs more affordable. Here are his prepared remarks
Jul 14, 2017 Press Release
Today, Energy and Commerce Ranking Member Frank Pallone, Jr. (D-NJ) released the following statement after the FCC’s Incentive Auction Task Force announced that broadcasters have requested $2.1 billion – significantly more than the $1.75 billion set aside – to cover costs related to the auction.
Jul 13, 2017 Press Release
Bipartisan Energy and Commerce Committee leaders sent a letter to the U.S. Department of Health and Human Services regarding reports of opioid “patient brokers”.
Issues:
Jul 13, 2017 Press Release
Ranking Member Pallone's statement on the Senate Republican's updated draft of the Trumpcare bill.
Issues:
Jul 13, 2017 Press Release
Ranking Member Pallone's opening remarks at an Environment Subcommittee markup of the, “Drinking Water System Improvement Act.”
Jul 12, 2017 Press Release
Ranking Member Pallone's remarks on the House Floor during consideration of the Food and Drug Administration Reauthorization Act.
Issues:

Pages